Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival

Retrovirology

Volumn 4, Issue , 2007, Pages

  Datta, Antara ^a   Silverman, Lee ^a,b   Phipps, Andrew J ^a   Hiraragi, Hajime ^a,c   Ratner, Lee ^d   Lairmore, Michael D ^a,e  

^a OHIO STATE UNIVERSITY   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

^c GENENTECH INC   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; CHECKPOINT KINASE 1; POLO LIKE KINASE 1; PROTEIN P30; PROTEIN TYROSINE PHOSPHATASE; SERINE; TYROSINE; CDC25C PHOSPHATASE; CELL CYCLE PROTEIN; CORE PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL SURVIVAL; CONTROLLED STUDY; EXPRESSION VECTOR; GENETIC TRANSFECTION; GENOTOXICITY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LENTIVIRINAE; LEUKEMIA CELL LINE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; BIOSYNTHESIS; CELL LINE; CYTOLOGY; DNA MICROARRAY; GENETIC TRANSDUCTION; GENETICS; IMMUNOLOGY; METABOLISM; METHODOLOGY; PHOSPHORYLATION; PHYSIOLOGY; REGULATOR GENE;

HUMAN T-LYMPHOTROPIC VIRUS 1; LENTIVIRUS;

APOPTOSIS; CDC25 PHOSPHATASE; CELL CYCLE PROTEINS; CELL LINE; CELL SURVIVAL; G2 PHASE; GENES, PX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; JURKAT CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; T-LYMPHOCYTES; TRANSDUCTION, GENETIC; TRANSFECTION; VIRAL CORE PROTEINS;

EID: 34547774658     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-4-49     Document Type: Article

References (66)

1. Taylor GP Matsuoka M Natural history of adult T-cell leukemia/lymphoma and approaches to therapy Oncogene 2005, 24:6047-6057 10.1038/ sj.onc.1208979 16155611
2. Mahieux R Gessain A HTLV-1 and associated adult T-cell leukemia/lymphoma Rev Clin Exp Hematol 2003, 7:336-361 15129647
3. Yoshida M Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis Oncogene 2005, 24:5931-5937 10.1038/sj.onc.1208981 16155600
4. Franchini G Fukumoto R Fullen JR T-cell control by human T-cell leukemia/ lymphoma virus type 1 Int J Hematol 2003, 78:280-296 14686485
5. Kashanchi F Brady JN Transcriptional and post-transcriptional gene regulation of HTLV-1 Oncogene 2005, 24:5938-5951 10.1038/sj.onc.1208973 16155601
6. Ratner L Pathogenesis and treatment of human T-cell leukemia virus infection Immunol Res 2005, 32:217-223 10.1385/IR:32:1-3:217 16106073
7. Giam CZ Jeang KT HTLV-1 Tax and adult T-cell leukemia Front Biosci 2007, 12:1496-1507 10.2741/2163 17127397
8. Younis I Green PL The Human T-cell leukemia virus Rex protein Front Biosci 2005, 10:431-445 10.2741/1539 15574380
9. Koralnik IJ Fullen J Franchini G The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments J Virol 1993, 67:2360-2366 240398 8445734
10. Ciminale V Pavlakis GN Derse D Cunningham CP Felber BK Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: Novel mRNAs and proteins produced by HTLV type I J Virol 1992, 66:1737-1745 240923 1310774
11. Koralnik IJ Gessain A Klotman ME Lo MA Berneman ZN Franchini G Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I Proc Natl Acad Sci U S A 1992, 89:8813-8817 50011 1528897 10.1073/pnas.89.18.8813
12. Cereseto A Berneman Z Koralnik I Vaughn J Franchini G Klotman ME Differential expression of alternatively spliced pX mRNAs in HTLV-I-infected cell lines Leukemia 1997, 11:866-870 10.1038/ sj.leu.2400665 9177442
13. Dekaban GA Peters AA Mulloy JC Johnson JM Trovato R Rivadeneira E Franchini G The HTLV-I orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits Virology 2000, 274:86-93 10.1006/viro.2000.0406 10936091
14. Pique C Uretavidal A Gessain A Chancerel B Gout O Tamouza R Agis F Dokhelar MC Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides J Exp Med 2000, 191: 567-572 10.1084/ jem.191.3.567 10662802
15. Awasthi S Sharma A Wong K Zhang J Matlock EF Rogers L Motloch P Takemoto S Taguchi H Cole MD Luscher B Dittrich O Tagami H Nakatani Y McGee M Girard AM Gaughan L Robson CN Monnat RJ Jr. Harrod R A Human T-Cell Lymphotropic Virus Type 1 Enhancer of Myc Transforming Potential Stabilizes Myc-TIP60 Transcriptional Interactions Mol Cell Biol 2005, 25:6178-6198 1168837 15988028 10.1128/MCB.25.14.6178-6198.2005
16. Bartoe JT Albrecht B Collins ND Robek MD Ratner L Green PL Lairmore MD Functional role of pX open reading frame II of human T- lymphotropic virus type 1 in maintenance of viral loads in vivo J Virol 2000, 74:1094-100 111443 10627519 10.1128/JVI.74.3.1094-1100.2000
17. Silverman LR Phipps AJ Montgomery A Ratner L Lairmore MD Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: Evidence of in vivo reversion J Virol 2004, 78:3837-3845 374265 15047799 10.1128/JVI.78.8.3837-3845.2004
18. Green PL HTLV-1 p30II: Selective repressor of gene expression Retrovirology 2004, 1-40 543446 15563375 10.1186/1742-4690-1-40
19. Younis I Khair L Dundr M Lairmore MD Franchini G Green PL Repression of Human T-Cell Leukemia Virus Type 1 and Type 2 Replication by a Viral mRNA-Encoded Posttranscriptional Regulator J Virol 2004, 78:11077-11083 521841 15452228 10.1128/JVI.78.20.11077-11083.2004
20. Ghorbel S Sinha-Datta U Dundr M Brown M Franchini G Nicot C HTLV-I p30 nuclear/nucleolar retention is mediated through interactions with RNA and a constituent of the 60s ribosomal subunit J Biol Chem 2006, 17008317
21. Nicot C Dundr M Johnson JM Fullen JR Alonzo N Fukumoto R Princler GL Derse D Misteli T Franchini G HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication Nat Med 2004, 10:197-201 10.1038/nm984 14730358
22. Datta A Sinha-Datta U Dhillon NK Buch S Nicot C The HTLV-I p30 interferes with TLR4 signaling and modulates the release of pro- and anti-inflammatory cytokines from human macrophages J Biol Chem 2006, 281:23414-23424 10.1074/jbc.M600684200 16785240
23. Zhang W Nisbet JW Bartoe JT Ding W Lairmore MD Human T-lymphotropic virus type 1 p30(II) functions as a transcription factor and differentially modulates CREB-responsive promoters J Virol 2000, 74:11270-11277 113231 11070026 10.1128/JVI.74.23.11270-11277.2000
24. Zhang W Nisbet JW Albrecht B Ding W Kashanchi F Bartoe JT Lairmore MD Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300 J Virol 2001, 75:9885-9895 114560 11559821 10.1128/JVI.75.20.9885-9895.2001
25. Michael B Nair AM Hiraragi H Shen L Feuer G Boris-Lawrie K Lairmore MD Human T lymphotropic virus type-1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes Retrovirology 2004, 1:39 538277 15560845 10.1186/1742-4690-1-39
26. Michael B Nair AM Datta A Hiraragi H Ratner L Lairmore MD Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30(II)-mediated repression of LTR transcriptional activity Virology 2006, 354:225-239 10.1016/j.virol.2006.07.002 16890266
27. Sinha-Datta U Datta A Ghorbel S Duc DM Nicot C HTLV-I Rex and p30 interactions govern the switch between virus latency and replication J Biol Chem 2007, 17360706
28. Baydoun H Duc-Dodon M Lebrun S Gazzolo L Bex F Regulation of the human T-cell leukemia virus gene expression depends on the localization of regulatory proteins Tax, Rex and p30(II) in specific nuclear subdomains Gene 2006, 17071021
29. Krek W Nigg EA Mutations of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: Evidence for a double block to p34cdc2 kinase activation in vertebrates EMBO J 1991, 10:3331-3341 453060 1655418
30. Krek W Nigg EA Cell cycle regulation of vertebrate p34cdc2 activity: identification of Thr161 as an essential in vivo phosphorylation site New Biol 1992, 4:323-329 1622929
31. Draetta G Eckstein J Cdc25 protein phosphatases in cell proliferation Biochim Biophys Acta 1997, 1332:M53-M63 9141461
32. Graves PR Lovly CM Uy GL Piwnica-Worms H Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding Oncogene 2001, 20:1839-1851 10.1038/sj.onc.1204259 11313932
33. Ng CP Lee HC Ho CW Arooz T Siu WY Lau A Poon RY Differential mode of regulation of the checkpoint kinases CHK1 and CHK2 by their regulatory domains J Biol Chem 2004, 279:8808-8819 10.1074/jbc.M312215200 14681223
34. Peng CY Graves PR Thoma RS Wu Z Shaw AS Piwnica-Worms H Mitotic and G2 checkpoint control: Regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216 Science 1997, 277:1501-1505 10.1126/science.277.5331.1501 9278512
35. Sanchez Y Wong C Thoma RS Richman R Wu Z Piwnica-Worms H Elledge SJ Conservation of the Chk1 checkpoint pathway in mammals: Linkage of DNA damage to Cdk regulation through Cdc25 Science 1997, 277:1497-1501 10.1126/science.277.5331.1497 9278511
36. Jeggo PA Lobrich M Contribution of DNA repair and cell cycle checkpoint arrest to the maintenance of genomic stability DNA Repair (Amst) 2006, 5:1192-1198 10.1016/j.dnarep.2006.05.011 16797253
37. Matei IR Guidos CJ Danska JS ATM-dependent DNA damage surveillance in T-cell development and leukemogenesis: The DSB connection Immunol Rev 2006, 209:142-158 10.1111/j.0105-2896.2006.00361.x 16448540
38. Elia AE Cantley LC Yaffe MB Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates Science 2003, 299:1228-1231 10.1126/science.1079079 12595692
39. Hutchins JR Clarke PR Many fingers on the mitotic trigger: post-translational regulation of the Cdc25C phosphatase Cell Cycle 2004, 3:41-45 14657664
40. Roshak AK Capper EA Imburgia C Fornwald J Scott G Marshall LA The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase Cell Signal 2000 12 405 411 10.1016/S0898-6568(00)00080-2 11202906
41. Toyoshima-Morimoto F Taniguchi E Nishida E Plk1 promotes nuclear translocation of human Cdc25C during prophase EMBO rep 2002, 3:341-348 1084057 11897663 10.1093/embo-reports/kvf069
42. Collins ND Newbound GC Ratner L Lairmore MD In vitro CD4(+) lymphocyte transformation and infection in a rabbit model with a molecular clone of human T-cell lymphotropic virus type 1 J Virol 1996, 70:7241-7246 190781 8794375
43. Collins ND D'Souza C Albrecht B Robek MD Ratner L Ding W Green PL Lairmore MD Proliferation response to interleukin-2 and Jak/Stat activation of T cells immortalized by human T-cell lymphotropic virus type 1 is independent of open reading frame I expression J Virol 1999, 73:9642-9649 113003 10516077
44. Robek MD Wong FH Ratner L Human T-Cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes J Virol 1998, 72:4458-4462 109681 9557741
45. Kaufmann SH Cell death induced by topoisomerase-targeted drugs: More questions than answers Biochim Biophys Acta 1998, 1400:195-211 9748575
46. Kluck RM Bossy-Wetzel E Green DR Newmeyer DD The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis Science 1997, 275:1132-1136 10.1126/science.275.5303.1132 9027315
47. Yang J Liu X Bhalla K Kim CN Ibrado AM Cai J Peng TI Jones DP Wang X Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked Science 1997, 275:1129 -132 10.1126/ science.275.5303.1129 9027314
48. Shi J Zheng D Man K Fan ST Xu R TRAIL: A potential agent for cancer therapy Curr Mol Med 2003, 3:727-736 10.2174/1566524033479401 14682494
49. Doree M Hunt T From Cdc2 to Cdk1: When did the cell cycle kinase join its cyclin partner? J Cell Sci 2002, 115:2461-2464 12045216
50. O'Connell MJ Cimprich KA G2 damage checkpoints: What is the turn-on? J Cell Sci 2005, 118:1-6 10.1242/jcs.01626 15615778
51. van Vugt MA Medema RH Getting in and out of mitosis with Polo-like kinase-1 Oncogene 2005, 24:2844-2859 10.1038/sj.onc.1208617 15838519
52. Toyoshima-Morimoto F Taniguchi E Shinya N Iwamatsu A Nishida E Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase Nature 2001, 410 215-220 10.1038/35065617 11242082
53. Smits VA Klompmaker R Arnaud L Rijksen G Nigg EA Medema RH Polo-like kinase-1 is a target of the DNA damage checkpoint Nat Cell Biol 2000, 2:672-676 10.1038/35023629 10980711
54. Mortreux F Gabet AS Wattel E Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo Leukemia 2003, 17:26-38 10.1038/ sj.leu.2402777 12529656
55. Haoudi A Semmes OJ The HTLV-1 tax oncoprotein attenuates DNA damage induced G1 arrest and enhances apoptosis in p53 null cells Virology 2003, 305:229-239 10.1006/viro.2002.1642 12573569
56. Zimmerman ES Chen J Andersen JL Ardon O Dehart JL Blackett J Choudhary SK Camerini D Nghiem P Planelles V Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires Rad17 and Hus1 and induces nuclear BRCA1 and gamma-H2AX focus formation Mol Cell Biol 2004, 24:9286-9294 522272 15485898 10.1128/MCB.24.21.9286-9294.2004
57. Zimmerman ES Sherman MP Blackett JL Neidleman JA Kreis C Mundt P Williams SA Warmerdam M Kahn J Hecht FM Grant RM de Noronha CM Weyrich AS Greene WC Planelles V Human immunodeficiency virus type 1 vpr induces DNA replication stress in vitro and in vivo J Virol 2006, 80:10407-10418 1641771 16956949 10.1128/JVI.01212-06
58. Nakai-Murakami C Shimura M Kinomoto M Takizawa Y Tokunaga K Taguchi T Hoshino S Miyagawa K Sata T Kurumizaka H Yuo A Ishizaka Y HIV-1 Vpr induces ATM-dependent cellular signal with enhanced homologous recombination Oncogene 2006, 16983346
59. Zhao RY Bukrinsky M Elder RT HIV-1 viral protein R (Vpr) & host cellular responses Indian J Med Res 2005. 121:270-286 15817944
60. Roshal M Kim B Zhu Y Nghiem P Planelles V Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R J Biol Chem 2003, 278:25879-25886 10.1074/jbc.M303948200 12738771
61. Zhu Y Roshal M Li F Blackett J Planelles V Upregulation of survivin by HIV-1 Vpr Apoptosis 2003, 8:71-79 10.1023/A:1021653119934 12510154
62. Sanchez-Alcazar JA Ault JG Khodjakov A Schneider E Increased mitochondrial cytochrome c levels and mitochondrial hyperpolarization precede camptothecin-induced apoptosis in Jurkat cells Cell Death Differ 2000, 7:1090-1100 10.1038/sj.cdd.4400740 11139283
63. Wesselborg S Engels IH Rossmann E Los M Schulze-Osthoff K Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction Blood 1999, 93:3053-3063 10216102
64. Granville DJ Jiang H McManus BM Hunt DW Fas ligand and TRAIL augment the effect of photodynamic therapy on the induction of apoptosis in JURKAT cells Int Immunopharmacol 2001, 1:1831-1840 10.1016/ S1567-5769(01)00107-2 11562074
65. Yu Q Rose JH Zhang H Pommier Y Antisense inhibition of Chk2/hCds1 expression attenuates DNA damage-induced S and G2 checkpoints and enhances apoptotic activity in HEK-293 cells FEBS Lett 2001, 505:7-12 10.1016/S0014-5793(01)02756-9 11557032
66. Sauerwald TM Oyler GA Betenbaugh MJ Study of caspase inhibitors for limiting death in mammalian cell culture Biotechnol Bioeng 2003, 81:329-340 10.1002/bit.10473 12474256